Literature DB >> 8383700

Targeted transfection and expression of hepatitis B viral DNA in human hepatoma cells.

T J Liang1, W J Makdisi, S Sun, K Hasegawa, Y Zhang, J R Wands, C H Wu, G Y Wu.   

Abstract

A soluble DNA carrier system consisting of an asialoglycoprotein covalently linked to poly-L-lysine was used to bind DNA and deliver hepatitis B virus (HBV) DNA constructs to asialoglycoprotein receptor-positive human hepatoma cells. 4 d after transfection with surface or core gene expression constructs, HBsAg and HBeAg in the media were measured to be 16 ng/ml and 32 U/ml per 10(7) cells, respectively. Antigen production was completely inhibited by the addition of an excess of asialoorosomucoid. On the other hand, asialoglycoprotein receptor-negative human hepatoma cells, SK-Hep1, did not produce any viral antigens under identical conditions after incubation with HBV DNA complexed to a conjugate composed of asialoorosomucoid and poly-L-lysine. Using a complete HBV genome construct, HBsAg and HBeAg levels reached 16 ng/ml and 16 U/ml per 10(7) cells, respectively. Northern blots revealed characteristic HBV RNA transcripts including 3.5-, 2.4-, and 2.1-kb fragments. Intracellular and extracellular HBV DNA sequences including relaxed circular, linear and single stranded forms were detected by Southern blot hybridization. Finally, 42-nm Dane particles purified from the spent cultures medium were visualized by electron microscopy. This study demonstrates that a targetable DNA carrier system can transfect HBV DNA in vitro resulting in the production of complete HBV virions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8383700      PMCID: PMC288084          DOI: 10.1172/JCI116287

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks.

Authors:  J Summers; J M Smolec; R Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

2.  Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA.

Authors:  C Sureau; J L Romet-Lemonne; J I Mullins; M Essex
Journal:  Cell       Date:  1986-10-10       Impact factor: 41.582

3.  Phenotypical stability of a human hepatoma cell line, HuH-7, in long-term culture with chemically defined medium.

Authors:  H Nakabayashi; K Taketa; T Yamane; M Miyazaki; K Miyano; J Sato
Journal:  Gan       Date:  1984-02

4.  Replication of the genome of a hepatitis B--like virus by reverse transcription of an RNA intermediate.

Authors:  J Summers; W S Mason
Journal:  Cell       Date:  1982-06       Impact factor: 41.582

5.  Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.

Authors:  M A Sells; M L Chen; G Acs
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

6.  Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication.

Authors:  H E Blum; E Galun; T J Liang; F von Weizsäcker; J R Wands
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

Review 7.  One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice.

Authors:  J Fogh; J M Fogh; T Orfeo
Journal:  J Natl Cancer Inst       Date:  1977-07       Impact factor: 13.506

8.  Direct injection of hepatitis B virus DNA into liver induced hepatitis in adult rats.

Authors:  K Kato; Y Kaneda; M Sakurai; M Nakanishi; Y Okada
Journal:  J Biol Chem       Date:  1991-11-25       Impact factor: 5.157

9.  Receptor-mediated in vitro gene transformation by a soluble DNA carrier system.

Authors:  G Y Wu; C H Wu
Journal:  J Biol Chem       Date:  1987-04-05       Impact factor: 5.157

10.  Replication strategy of human hepatitis B virus.

Authors:  H Will; W Reiser; T Weimer; E Pfaff; M Büscher; R Sprengel; R Cattaneo; H Schaller
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

View more
  3 in total

Review 1.  Pharmaceutical approach to somatic gene therapy.

Authors:  F D Ledley
Journal:  Pharm Res       Date:  1996-11       Impact factor: 4.200

Review 2.  Delivery of DNA into mammalian cells by receptor-mediated endocytosis and gene therapy.

Authors:  J Guy; D Drabek; M Antoniou
Journal:  Mol Biotechnol       Date:  1995-06       Impact factor: 2.695

3.  Antisense therapy of hepatitis B virus infection.

Authors:  W B Offensperger; S Offensperger; H E Blum
Journal:  Mol Biotechnol       Date:  1998-04       Impact factor: 2.695

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.